Oorsprong van het eerstegraads netwerk van Jens Kaufmann
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
PentixaPharm GmbH
 PentixaPharm GmbH Miscellaneous Commercial ServicesCommercial Services Pentixapharm GmbH engages in the development, production, marketing, and distribution of medicines and radiopharmaceutical products, which act on the CXCR4 receptor. The company was founded on May 14, 2019 and is headquartered in Wuerzburg, Germany.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jens Kaufmann via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| 1717 Life Sciences Ventures GmbH | Investment Managers | Private Equity Investor Private Equity Investor | |
OctreoPharm Sciences GmbH
 OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Founder | |
Molecular Insight Pharmaceuticals GmbH
 Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of Lantheus Holdings, Inc., Molecular Insight Pharmaceuticals GmbH develops and commercializes innovative molecular imaging pharmaceuticals. The company is based in Wuerzburg, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Pharma GmbH
 Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ECKERT & ZIEGLER SE | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| ECKERT & ZIEGLER BEBIG | Pharmaceuticals: Major | Director/Board Member | |
| Polyventures GmbH | Chief Executive Officer |
Statistieken
Internationaal
| Duitsland | 6 |
| Oostenrijk | 2 |
| België | 2 |
Sectoraal
| Health Technology | 6 |
| Finance | 2 |
Operationeel
| Chief Executive Officer | 4 |
| Private Equity Investor | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Hakim Bouterfa | 6 |
| Anna Steeger | 4 |
- Beurs
- Insiders
- Jens Kaufmann
- Bedrijfsconnecties
